Authors:
Johnson, KA
Lopera, F
Jones, K
Becker, A
Sperling, R
Hilson, J
Londono, J
Siegert, I
Arcos, M
Moreno, S
Madrigal, L
Ossa, J
Pineda, N
Ardila, A
Roselli, M
Albert, MS
Kosik, KS
Rios, A
Citation: Ka. Johnson et al., Presenilin-1-associated abnormalities in regional cerebral perfusion, NEUROLOGY, 56(11), 2001, pp. 1545-1551
Authors:
Raitskin, O
Cho, DSC
Sperling, J
Nishikura, K
Sperling, R
Citation: O. Raitskin et al., RNA editing activity is associated with splicing factors in InRNP particles: The nuclear pre-mRNA processing machinery, P NAS US, 98(12), 2001, pp. 6571-6576
Authors:
Sperling, R
Braunstein, N
Melin, J
Reicin, A
Citation: R. Sperling et al., Cyclooxygenase 2 inhibitors and thrombogenicity production: Comment on an article by Crofford et al, ARTH RHEUM, 44(5), 2001, pp. 1229-1230
Authors:
Saag, K
van der Heijde, D
Fisher, C
Samara, A
DeTora, L
Bolognese, J
Sperling, R
Daniels, B
Citation: K. Saag et al., Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs - A 6-week and a 1-year trial in patients with osteoarthritis, ARCH FAM M, 9(10), 2000, pp. 1124-1134
Authors:
Pitt, J
Schluchter, M
Jenson, H
Kovacs, A
LaRussa, P
McIntosh, K
Boyer, P
Cooper, E
Goldfarb, J
Hammill, H
Hodes, D
Peavy, H
Sperling, R
Tuomala, R
Shearer, W
Citation: J. Pitt et al., Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the (PC2)-C-2 HIV study: The role of EBV shedding, J ACQ IMM D, 19(5), 1998, pp. 462-470